IL123202A0 - Method for determining genetic predisposition for seronegative spondzloarthropathies and products useful therefor - Google Patents

Method for determining genetic predisposition for seronegative spondzloarthropathies and products useful therefor

Info

Publication number
IL123202A0
IL123202A0 IL12320296A IL12320296A IL123202A0 IL 123202 A0 IL123202 A0 IL 123202A0 IL 12320296 A IL12320296 A IL 12320296A IL 12320296 A IL12320296 A IL 12320296A IL 123202 A0 IL123202 A0 IL 123202A0
Authority
IL
Israel
Prior art keywords
seronegative
spondzloarthropathies
genetic predisposition
products useful
useful therefor
Prior art date
Application number
IL12320296A
Other languages
English (en)
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Publication of IL123202A0 publication Critical patent/IL123202A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
IL12320296A 1995-09-01 1996-08-16 Method for determining genetic predisposition for seronegative spondzloarthropathies and products useful therefor IL123202A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/522,942 US5753442A (en) 1995-09-01 1995-09-01 Method for determining genetic predisposition for seronegative spondyloarthropathies and products useful therefor
PCT/US1996/013256 WO1997009450A1 (en) 1995-09-01 1996-08-16 Method for determining genetic predisposition for seronegative spondyloarthropathies and products useful therefor

Publications (1)

Publication Number Publication Date
IL123202A0 true IL123202A0 (en) 1998-09-24

Family

ID=24083009

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12320296A IL123202A0 (en) 1995-09-01 1996-08-16 Method for determining genetic predisposition for seronegative spondzloarthropathies and products useful therefor

Country Status (9)

Country Link
US (1) US5753442A (de)
EP (1) EP0847448B1 (de)
AT (1) ATE220425T1 (de)
AU (1) AU717278B2 (de)
DE (1) DE69622275T2 (de)
DK (1) DK0847448T3 (de)
ES (1) ES2179948T3 (de)
IL (1) IL123202A0 (de)
WO (1) WO1997009450A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4711963B2 (ja) * 2003-09-15 2011-06-29 オクラホマ メディカル リサーチ ファウンデーション 炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法
KR101323827B1 (ko) * 2010-01-08 2013-10-31 키스트 유럽 에프게엠베하 강직성척추염 진단용 프라이머 및 이를 이용한 강직성 척추염 진단 방법
KR101606530B1 (ko) 2014-04-08 2016-03-25 주식회사 현일바이오 Hla-b*27 및 hla-b*51의 동시 검출 방법 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965189A (en) * 1986-07-01 1990-10-23 University Of Massachusetts Medical School Probes for the determination of the proclivity for development of autoimmune diseases
GB9024005D0 (en) * 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid

Also Published As

Publication number Publication date
US5753442A (en) 1998-05-19
AU6725696A (en) 1997-03-27
DE69622275D1 (de) 2002-08-14
WO1997009450A1 (en) 1997-03-13
ES2179948T3 (es) 2003-02-01
AU717278B2 (en) 2000-03-23
DK0847448T3 (da) 2002-09-02
DE69622275T2 (de) 2003-06-18
ATE220425T1 (de) 2002-07-15
EP0847448A1 (de) 1998-06-17
EP0847448B1 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
IL114564A (en) Method for the sensitive detection of nucleic acids
EP0915173A3 (de) Reagentiensatz und Verfahren für Fluoreszenzerkennungstest
GB2202328B (en) Method for assaying nucleic acids, reagent combination and kit therefor
AU1400099A (en) High-throughput method and apparatus for identifying, quantitating and determining the purity of chemical compounds in mixtures
AU6403996A (en) Method and system for dna sequence determination and mutation detection
EP0639647A3 (de) Verfahren zum Nachweis Nukleinsäure-Sequenzen.
AU4040097A (en) Signal amplification method
AU4902590A (en) Assay method
EP0819251A4 (de) Verfahren zum nachweis von mikroorganismen
CA2126250A1 (en) Method, reagents and kits for the detection of neisseria gonorrhoeae
UA49827C2 (uk) СПОСІБ ДІАГНОСТИКИ ШИЗОФРЕНІЇ, ПАРА ПРАЙМЕРІВ ДЛЯ ВИКОРИСТАННЯ В СПОСОБІ, НАБІР ДЛЯ ВИЗНАЧЕННЯ АЛЕЛІ E<font face="Symbol">r</font> МІКРОСАТЕЛІТА HUMTH01
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
CA2139306A1 (fr) Procede de determination de la taille en nucleotides de fragments d'adn
GB2307041B (en) Sheets,kits and methods for detecting antigens or antibodies
IL123202A0 (en) Method for determining genetic predisposition for seronegative spondzloarthropathies and products useful therefor
EP0906574A4 (de) Verfahren und sets zur detektion von endotoxinen
MX9800775A (es) Metodos para determinar el genotipo del color de la piel de un cerdo.
WO1996014432A3 (en) Medium for detecting target microbes in a sample
EP0781853A3 (de) Verfahren zur Messung von Nukleinsäuren
EP0892069A3 (de) Verfahren zur Bestimmung des Histocompatibilitätsantigenlokus Klasse II
WO2002048398A3 (de) In situ-hybridisierungs-anordnung zum spezifischen nachweis von mikroorganismen
ES2189459T3 (es) Deteccion de resistencias a antibioticos en microorganismos.
CA2222513A1 (en) Agents binding specifically to biotin for detecting damaged nucleic acid bases
WO1998026091A3 (en) Method and kit for HLA class I typing
EP1106688A4 (de) Gene zum nachweis von bakterien und nachweismethode unter deren verwendung